Latest Survival of motor neuron Stories
Scientist from preclinical CRO, PharmOptima, presents new assay at the 2013 International SMA Research Group Meeting. Portage, MI (PRWEB) July 09, 2013
There is no specific drug to treat spinal muscular atrophy (SMA), a family of motor neuron diseases that in its most severe form is the leading genetic cause of infant death in the United States and affects one in 6,000 people overall.
An abnormally low level of a protein in certain nerve cells is linked to movement problems that characterize the deadly childhood disorder spinal muscular atrophy, new research in animals suggests.
- A political dynamiter.